| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.2B | $0.1B | — | — |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B |
| SG&A Expense | — | — | — | — | — |
| Operating Income | $-0.2B | $0.0B | $-0.0B | $-0.1B | $-0.1B |
| Net Income | $-0.1B | $0.1B | $-0.0B | $-0.1B | $-0.1B |
| EPS (Basic) | $-3.47 | $1.76 | $-0.20 | $-3.02 | $-8.16 |
| EPS (Diluted) | $-3.47 | $1.68 | $-0.20 | $-3.02 | $-8.16 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $0.4B | $0.5B | $0.5B | $0.3B | $0.3B |
| Current Assets | $0.3B | $0.4B | $0.4B | $0.2B | $0.3B |
| Cash & Equivalents | $0.1B | $0.1B | $0.1B | $0.0B | $0.3B |
| Total Liabilities | $0.1B | $0.1B | $0.2B | $0.0B | $0.0B |
| Current Liabilities | $0.0B | $0.0B | $0.2B | $0.0B | $0.0B |
| Stockholders' Equity | $0.3B | $0.4B | $0.2B | $0.2B | $0.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $-0.1B | $-0.0B | $0.1B | $-0.1B | $-0.1B |
| Investing Cash Flow | $0.1B | $-0.0B | $-0.1B | $-0.1B | $-0.0B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.0B | $0.1B | $0.0B | $0.0B | $0.3B |